NO984033L - Nye indol og indazol forbindelser, en fremgangsmÕte ved deres fremstilling og farmas°ytiske forbindelser som inneholder dem - Google Patents

Nye indol og indazol forbindelser, en fremgangsmÕte ved deres fremstilling og farmas°ytiske forbindelser som inneholder dem

Info

Publication number
NO984033L
NO984033L NO984033A NO984033A NO984033L NO 984033 L NO984033 L NO 984033L NO 984033 A NO984033 A NO 984033A NO 984033 A NO984033 A NO 984033A NO 984033 L NO984033 L NO 984033L
Authority
NO
Norway
Prior art keywords
indazole
preparation
disorders
compounds
reduction
Prior art date
Application number
NO984033A
Other languages
English (en)
Other versions
NO984033D0 (no
NO316271B1 (no
Inventor
Gilbert Lavielle
Olivier Muller
Christine Vayssettes-Courchay
Jean-Jacques Descombes
Tony Verbeuren
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO984033D0 publication Critical patent/NO984033D0/no
Publication of NO984033L publication Critical patent/NO984033L/no
Publication of NO316271B1 publication Critical patent/NO316271B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19984033A 1997-09-03 1998-09-02 Nye indol- og indazolforbindelser, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetninger som inneholder dem NO316271B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710939A FR2767827A1 (fr) 1997-09-03 1997-09-03 Nouveaux derives de l'indole et de l'indazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO984033D0 NO984033D0 (no) 1998-09-02
NO984033L true NO984033L (no) 1999-03-04
NO316271B1 NO316271B1 (no) 2004-01-05

Family

ID=9510710

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984033A NO316271B1 (no) 1997-09-03 1998-09-02 Nye indol- og indazolforbindelser, en fremgangsmåte ved deres fremstillingog farmasöytiske sammensetninger som inneholder dem

Country Status (19)

Country Link
US (2) US6020336A (no)
EP (1) EP0902027B1 (no)
JP (1) JPH11130773A (no)
CN (2) CN1510034A (no)
AT (1) ATE203531T1 (no)
AU (1) AU736602B2 (no)
BR (1) BR9803318A (no)
CA (1) CA2246485C (no)
DE (1) DE69801196T2 (no)
DK (1) DK0902027T5 (no)
ES (1) ES2162404T3 (no)
FR (1) FR2767827A1 (no)
GR (1) GR3036678T3 (no)
HU (1) HUP9801977A1 (no)
NO (1) NO316271B1 (no)
NZ (1) NZ331683A (no)
PL (1) PL328323A1 (no)
PT (1) PT902027E (no)
ZA (1) ZA988072B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2356638A1 (en) * 1998-12-23 2000-07-06 Nps Allelix Corp. Indole and indolizidine derivatives for the treatment of migraine
YU54202A (sh) * 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
HN2001000008A (es) 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
BR0110302A (pt) 2000-04-18 2003-01-14 Agouron Pharma Compostos de pirazol para inibição de proteìnas cinase, sal e pró-droga farmaceuticamente aceitável, metabólito farmaceuticamente ativo ou sal farmaceuticamente aceitável de metabólito, composição farmacêutica, método de tratamento de condição doentia em mamìferos mediada pela atividade de proteìna cinase, método de modulação ou inibição da atividade de um receptor de proteìna cinase
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
US20070105841A1 (en) * 2000-08-14 2007-05-10 Breitenbucher J G Method for treating allergies using substituted pyrazoles
US7589202B2 (en) 2000-08-14 2009-09-15 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
FR2829134B1 (fr) 2001-08-28 2006-11-24 Atofina Procede de preparation de (meth) acrylates d'alkylimidazolidone
US20030073672A1 (en) * 2001-09-05 2003-04-17 Breitenbucher J. Guy Method for treating allergies using substituted pyrazoles
RU2295326C1 (ru) * 2005-10-05 2007-03-20 Елена Николаевна Лаптева Комплексный способ снижения избыточной массы тела
JPWO2012086735A1 (ja) * 2010-12-22 2014-06-05 大正製薬株式会社 縮合複素環化合物
CN102617548A (zh) * 2011-01-31 2012-08-01 北京赛林泰医药技术有限公司 作为gpr受体激动剂的双环杂芳基化合物及其组合物和应用
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
US9951038B2 (en) 2012-12-27 2018-04-24 Purdue Pharma L.P. Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
US20150252022A1 (en) * 2014-03-10 2015-09-10 Innov17 Llc Retinoic acid receptor-related orphan receptor modulators and uses thereof
EP3116866A4 (en) * 2014-03-10 2017-07-26 Innov17 LLC Retinoic acid receptor-related orphan receptor modulators and uses thereof
US11459308B2 (en) 2016-12-05 2022-10-04 Microbiotix, Inc. Broad spectrum inhibitors of filoviruses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
TW203049B (no) * 1990-04-13 1993-04-01 Yamanouchi Pharma Co Ltd
EP0597112A4 (en) * 1992-03-27 1994-06-22 Kyoto Pharma Ind Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor.
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
GB9402016D0 (en) * 1994-02-02 1994-03-30 Merck Sharp & Dohme Therapeutic agents
EP0759918A1 (en) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists
GB2289465A (en) * 1994-05-19 1995-11-22 Merck Sharp & Dohme Five-membered heteroaromatic 5-HT receptor agonists
EP0804434A1 (en) * 1994-08-02 1997-11-05 MERCK SHARP & DOHME LTD. Azetidine, pyrrolidine and piperidine derivatives
ZA965837B (en) * 1995-07-11 1997-01-31 Merck & Co Inc A triazolylmethyl-indole ethylamine bisulfate salt
AU707750B2 (en) * 1995-08-07 1999-07-22 Merck Sharp & Dohme Limited Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives

Also Published As

Publication number Publication date
HK1019738A1 (en) 2000-02-25
CA2246485A1 (fr) 1999-03-03
CN1218052A (zh) 1999-06-02
CN1510034A (zh) 2004-07-07
US6020336A (en) 2000-02-01
US6046205A (en) 2000-04-04
HUP9801977A1 (hu) 2000-11-28
DE69801196T2 (de) 2002-03-14
EP0902027A1 (fr) 1999-03-17
NO984033D0 (no) 1998-09-02
NO316271B1 (no) 2004-01-05
NZ331683A (en) 2000-01-28
BR9803318A (pt) 2000-02-08
FR2767827A1 (fr) 1999-03-05
PL328323A1 (en) 1999-03-15
JPH11130773A (ja) 1999-05-18
AU8306898A (en) 1999-03-18
DE69801196D1 (de) 2001-08-30
GR3036678T3 (en) 2001-12-31
ZA988072B (en) 1999-03-09
PT902027E (pt) 2001-11-30
HU9801977D0 (en) 1998-10-28
ATE203531T1 (de) 2001-08-15
CN1087741C (zh) 2002-07-17
AU736602B2 (en) 2001-08-02
ES2162404T3 (es) 2001-12-16
DK0902027T3 (da) 2001-10-15
DK0902027T5 (da) 2001-12-03
CA2246485C (fr) 2004-04-20
EP0902027B1 (fr) 2001-07-25

Similar Documents

Publication Publication Date Title
NO984033D0 (no) Nye indol og indazol forbindelser, en fremgangsmÕte ved deres fremstilling og farmas°ytiske forbindelser som inneholder dem
NO953879D0 (no) Kinoliner som inhibitorer for fosfodiesterase av type IV
EP0987263A3 (en) Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
NO20055919L (no) 3-Subtituerte,5,6-Diaryl-Pyrazin-2-Karboksamid og 2-Sulfonamidderivater som CB1-Modulatorar
DE68907921D1 (de) Substituierte pyrrol-, pyrazol- und triazol-angiotensin ii-antagonisten.
CA2207404A1 (en) Imidazole derivatives as protein kinase inhibitors in particular egf-r tyrosine kinase
DK0695301T3 (da) Indolderivater som 5-HT1-lignende agonister til anvendelse ved migræne
CA2378369A1 (en) Small molecules useful in the treatment of inflammatory disease
DK1000029T3 (da) Norcisaprid nyttig med hensyn til 5-HT3- og 5-HT4- medierede lidelser
CA2292895A1 (en) Cyanoguanidines as cell proliferation inhibitors
NO931040L (no) Indol- og indazolderivater, fremgangsmaate til fremstilling og anvendelse derav
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
AU5614198A (en) Isoquinolinamine and phthalazinamine derivatives which interact with crf receptors
CA2273328A1 (en) 5-cyclo indole compounds as 5-ht1d receptor ligands
de S Rosa et al. A Convenient Synthesis of Pyrazole‐imidazoline Derivatives by Microwave Irradiation
NO961333L (no) Nye pyrazolderivater som angiotensin-II-antagonister
DE69329645D1 (de) Imidazol-, triazol- und tetrazolderivate
NO993180D0 (no) N-(pyridinylamino)isoindoler og beslektede forbindelser
DK0804433T3 (da) Indolderivat til behandling af migræne
YU29496A (sh) So pirolidinil metil indola
NO20065661L (no) Indol-2-onderivater for behandling av sentralnerveforstyrrelser, gastrointestinale forstyrrelser og kardiovaskulaere forstyrrelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees